2-231000444-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_139073.5(SPATA3):​c.380G>A​(p.Gly127Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000665 in 1,549,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G127R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

SPATA3
NM_139073.5 missense

Scores

5
6
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.84

Publications

0 publications found
Variant links:
Genes affected
SPATA3 (HGNC:17884): (spermatogenesis associated 3) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
SPATA3 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19013095).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATA3NM_139073.5 linkc.380G>A p.Gly127Glu missense_variant Exon 2 of 5 ENST00000433428.7 NP_620712.2 Q8NHX4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATA3ENST00000433428.7 linkc.380G>A p.Gly127Glu missense_variant Exon 2 of 5 1 NM_139073.5 ENSP00000403804.2 Q8NHX4

Frequencies

GnomAD3 genomes
AF:
0.000256
AC:
39
AN:
152130
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000707
AC:
11
AN:
155614
AF XY:
0.0000485
show subpopulations
Gnomad AFR exome
AF:
0.00127
Gnomad AMR exome
AF:
0.0000408
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000458
AC:
64
AN:
1397434
Hom.:
0
Cov.:
38
AF XY:
0.0000406
AC XY:
28
AN XY:
689040
show subpopulations
African (AFR)
AF:
0.00155
AC:
49
AN:
31540
American (AMR)
AF:
0.0000281
AC:
1
AN:
35548
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25142
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35630
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79110
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49230
Middle Eastern (MID)
AF:
0.000703
AC:
4
AN:
5692
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1077624
Other (OTH)
AF:
0.000173
AC:
10
AN:
57918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152248
Hom.:
0
Cov.:
33
AF XY:
0.000296
AC XY:
22
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000891
AC:
37
AN:
41540
American (AMR)
AF:
0.0000654
AC:
1
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000263
Hom.:
0
Bravo
AF:
0.000348
ExAC
AF:
0.0000748
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 17, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.380G>A (p.G127E) alteration is located in exon 2 (coding exon 2) of the SPATA3 gene. This alteration results from a G to A substitution at nucleotide position 380, causing the glycine (G) at amino acid position 127 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Uncertain
0.089
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.055
.;T;T;T;.;T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.79
T;.;.;.;T;T
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.19
T;T;T;T;T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Benign
1.0
.;L;L;L;.;L
PhyloP100
3.8
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-4.8
.;D;D;D;.;D
REVEL
Uncertain
0.38
Sift
Pathogenic
0.0
.;D;D;D;.;D
Sift4G
Pathogenic
0.0
.;D;D;D;D;D
Vest4
0.93, 0.91
MVP
0.14
ClinPred
0.71
D
GERP RS
4.3
Varity_R
0.78
gMVP
0.086
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs568032493; hg19: chr2-231865159; API